Product Images Montelukast Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Montelukast Sodium NDC 42291-623 by Avkare, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

621 10 Montelukast

621 10 Montelukast

AVKARE Montelukast Sodium Tablets 10mg is a prescription medication that is intended for adults aged 15 years and above. The NDC code for this product is 42291-621-10, and it comes in a package of 1000 tablets. The attached patient leaflet for this medication should be dispensed to each patient. The text is a label and does not contain any additional information.*

Label 4229162290 Montelukast Sodium 2016 4mg Chewable

Label 4229162290 Montelukast Sodium 2016 4mg Chewable

This is a description of Avkare Chewable Tablets, the medication containing Montelukast Sodium, meant for pediatric patients aged between 2 to 5 years. The dosage details are mentioned in the circular that accompanies the medicine. The National Drug Code (NDC) for this medicine is 42291-622-90, and it comes with 90 tablets in the pack which is available only with a prescription. The pharmacist should provide the patient leaflet to each patient along with the prescription.*

Label 4229162390 Montelukast Sodium 2018 5mg Chewable

Label 4229162390 Montelukast Sodium 2018 5mg Chewable

montelukast sodium tablets and chewable tablets 1

montelukast sodium tablets and chewable tablets 1

This is a graph showing the change in height (in centimeters) over time on different treatments. The treatments compared are Montelukast Sodium 5 mg, Beclomethasone 336 mcg, and Placebo. The graph shows the height measurements over time for each treatment group.*

montelukast sodium tablets and chewable tablets 2

montelukast sodium tablets and chewable tablets 2

montelukast sodium tablets and chewable tablets 3

montelukast sodium tablets and chewable tablets 3

The text is describing a graph that shows the mean percent change from baseline over 15 weeks of treatment with either placebo or Montelukast Sodium. The x-axis represents the weeks in treatment, ranging from 0 to 15, with a washout period included. The y-axis represents the mean percent change from baseline.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.